The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2020
Filed:
Sep. 24, 2018
Applicant:
Zogenix International Limited, Berkshire, GB;
Inventors:
Khawla Abu-Izza, Berkeley, CA (US);
David Hickman, Newark, GB;
Glenn Morrison, Half Moon Bay, CA (US);
Brooks M. Boyd, Berkeley, CA (US);
Assignee:
ZOGENIX INTERNATIONAL LIMITED, Berkshire, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A23L 33/10 (2016.01); A61P 25/08 (2006.01); A61K 9/08 (2006.01); A61K 47/26 (2006.01); A61K 47/14 (2017.01); A61K 47/12 (2006.01); A23L 33/00 (2016.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A23L 33/10 (2016.08); A23L 33/30 (2016.08); A61K 9/08 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61P 25/08 (2018.01); A23V 2002/00 (2013.01); A23V 2200/3322 (2013.01);
Abstract
A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.